The short version
8 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Doxycycline Hyclate
Doxycycline Hyclate · DOXYCYCLINE HYCLATE 75 mg/1 · Tablet, Delayed Release · Oral · Alembic Pharmaceuticals Inc.
NDC 62332-0481-60 · 60 TABLET, DELAYED RELEASE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 23155-0141-01) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$2.58per unit
middle half $1.99–$4.84 · 70 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $2.58
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
1%of plans cover it
tier 4 · prior auth 0% · step therapy 0% · qty limit 0%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$146.99
Reported to Texas DSHS · 2026 annual filing · Alembic Pharmaceuticals Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for doxycycline hyclate (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA213075
- TE code
- AB
- Approval date
- Jan 3, 2022
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Doxycycline Hyclate, Tablet, Delayed Release, 200 mg (NDC 0591-4575-60)Jul 30, 2026
- Planned discontinuation — Doxycycline Hyclate, Tablet, Delayed Release, 50 mg (NDC 0591-4550-22)Jul 30, 2026
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Doxycycline Hyclate (Tablet, Delayed Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Actavis Pharma, Inc. | DOXYCYCLINE HYCLATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Actavis Pharma, Inc. | DOXYCYCLINE HYCLATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | DOXYCYCLINE HYCLATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | DOXYCYCLINE HYCLATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | DOXYCYCLINE HYCLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | DOXYCYCLINE HYCLATE 75 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | DOXYCYCLINE HYCLATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | DOXYCYCLINE HYCLATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | DOXYCYCLINE HYCLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | DOXYCYCLINE HYCLATE 75 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | DOXYCYCLINE HYCLATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | DOXYCYCLINE HYCLATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | DOXYCYCLINE HYCLATE 75 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | DOXYCYCLINE HYCLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mayne Pharma Commercial LLC | DOXYCYCLINE HYCLATE 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mayne Pharma Commercial LLC | DOXYCYCLINE HYCLATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mayne Pharma International Pty Ltd. | DOXYCYCLINE HYCLATE 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Solco Healthcare US LLC | DOXYCYCLINE HYCLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Solco Healthcare US LLC | DOXYCYCLINE HYCLATE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Solco Healthcare US LLC | DOXYCYCLINE HYCLATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sonoma Pharmaceuticals, Inc. | DOXYCYCLINE HYCLATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Doxycycline Hyclate — NDC 62332-0481-60," retrieved September 3, 2026, https://drugdashboards.com/drug/62332048160.
Free to cite with attribution — see how the data is put together.